COST EFFECTIVENESS ANALYSIS OF LETROZOLE COMPARED WITH TAMOXIFEN AS INITIAL ADJUVANT THERAPY FOR POSTMENOPAUSAL WOMEN WITH ENDOCRINE RESPONSIVE BREAST CANCER